Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.35% |
| 3 | Industrials | 11.13% |
| 4 | Consumer Discretionary | 10.88% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.4B
| $2.56M | ﹤0.01% |
+64,800
| New | +$2.63M |
|
1752
United Fire Group
UFCS
$1.32B
| $2.55M | ﹤0.01% |
68,910
-71,600
| -51% | -$2.64M |
|
1753
Adtran
ADTN
$798M
| $2.55M | ﹤0.01% |
202,899
-48,941
| -19% | -$496K |
|
1754
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.45B
| $2.55M | ﹤0.01% |
39,400
-919
| -2% | -$61K |
|
1755
Entrada Therapeutics
TRDA
$227M
| $2.55M | ﹤0.01% |
202,084
-50,551
| -20% | -$579K |
|
1756
Transcat
TRNS
$793M
| $2.55M | ﹤0.01% |
34,700
-60,500
| -64% | -$4.26M |
|
1757
Akebia Therapeutics
AKBA
$327M
| $2.55M | ﹤0.01% |
1,833,128
-1,760,005
| -49% | -$2.42M |
|
1758
Palisade Bio
PALI
$339M
| $2.55M | ﹤0.01% |
1,454,400
-928,100
| -39% | -$1.69M |
|
1759
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.71B
| $2.54M | ﹤0.01% |
56,300
+26,037
| +86% | +$1.19M |
|
1760
Horizon Bancorp
HBNC
$1.03B
| $2.54M | ﹤0.01% |
153,424
+32,524
| +27% | +$557K |
|
1761
Global X Copper Miners ETF NEW
COPX
$7.13B
| $2.54M | ﹤0.01% |
+33,297
| New | +$2.76M |
|
1762
SIGA Technologies
SIGA
$223M
| $2.54M | ﹤0.01% |
475,013
+96,913
| +26% | +$604K |
|
1763
Contango Silver & Gold Inc
CTGO
$529M
| $2.54M | ﹤0.01% |
135,278
+6,451
| +5% | +$170K |
|
1764
Organogenesis Holdings
ORGO
$308M
| $2.53M | ﹤0.01% |
1,068,538
+249,838
| +31% | +$865K |
|
1765
STAAR Surgical
STAA
$1.16B
| $2.53M | ﹤0.01% |
135,200
+97,400
| +258% | +$1.86M |
|
1766
Stratasys
SSYS
$697M
| $2.53M | ﹤0.01% |
323,400
-90,632
| -22% | -$887K |
|
1767
AEye
LIDR
$52.3M
| $2.52M | ﹤0.01% |
1,394,472
+1,322,472
| +1,837% | +$2.41M |
|
|
EWCZ
1768
DELISTED
European Wax Center
EWCZ
| $2.51M | ﹤0.01% |
434,900
+191,800
| +79% | +$955K |
|
|
CHA
1769
Chagee Holdings Ltd
CHA
$2.14B
| $2.51M | ﹤0.01% |
+269,700
| New | +$3.02M |
|
|
SFBS
1770
ServisFirst Bancshares
SFBS
$4.79B
| $2.51M | ﹤0.01% |
+34,400
| New | +$2.72M |
|
1771
Franklin International Low Volatility High Dividend Index ETF
LVHI
$5.3B
| $2.5M | ﹤0.01% |
61,700
-25,472
| -29% | -$1M |
|
1772
Comp X International
CIX
$329M
| $2.5M | ﹤0.01% |
106,949
-6,600
| -6% | -$156K |
|
1773
Lexicon Pharmaceuticals
LXRX
$1.02B
| $2.5M | ﹤0.01% |
1,600,500
+1,337,246
| +508% | +$1.94M |
|
1774
Alerian MLP ETF
AMLP
$13B
| $2.5M | ﹤0.01% |
47,415
+7,015
| +17% | +$357K |
|
1775
CNA Financial
CNA
$14.5B
| $2.49M | ﹤0.01% |
54,300
+33,600
| +162% | +$1.59M |
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.